Skip to main content
Pharming Group N.V. (PHAR)
NASDAQ: PHAR · Real-Time Price · USD
16.46
-0.46 (-2.72%)
At close: Apr 28, 2026, 4:00 PM EDT
16.42
-0.04 (-0.24%)
After-hours: Apr 28, 2026, 4:10 PM EDT

Pharming Group Revenue

In the year 2025, Pharming Group had annual revenue of $376.13M with 26.56% growth. Pharming Group had revenue of $106.53M in the quarter ending December 31, 2025, with 14.96% growth.

Revenue (ttm)
$376.13M
Revenue Growth
+26.56%
P/S Ratio
3.12
Revenue / Employee
$924,162
Employees
407
Market Cap
1.17B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025376.13M78.93M26.56%
Dec 31, 2024297.20M51.88M21.15%
Dec 31, 2023245.32M39.69M19.30%
Dec 31, 2022205.62M6.75M3.39%
Dec 31, 2021198.87M-13.30M-6.27%
Dec 31, 2020 Pro Pro Pro
Jan 1, 2020 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Novavax 1.12B
UroGen Pharma 109.79M
AbCellera Biologics 75.13M
Septerna 45.95M
EyePoint 31.37M
uniQure 16.10M
Zenas BioPharma 10.00M
DBV Technologies 5.64M
Revenue Rankings

PHAR News

More News